Encision (ECIA) Stock Analysis & Winston Score
Encision Inc. makes surgical tools used in operating rooms. The company specializes in electrosurgical instruments — devices that use electrical energy to cut tissue and stop bleeding during surgery. Its main customers are hospitals and surgical centers, and its flagship technology is a safety system called AEM (Active Electrode Monitoring) that reduces the risk of accidental burns to patients during minimally invasive surgery. Encision sells its products through a combination of hardware sales and a recurring blade and instrument business, meaning hospitals keep buying disposable tools after the initial purchase. The company operates primarily in the United States and is a small player in the broader surgical instruments market, competing against much larger companies like Medtronic and Stryker. Its AEM safety technology is a key differentiator, but the company's negative operating margin signals it is spending more than it earns, and sustaining profitability while competing against well-funded rivals remains the central challenge.
Winston Score: 24/100 — Weak
Weak fundamentals across most pillars.
- Quality: Mixed (8/30)
- Growth: Weak (1/20)
- Cash Flow: Weak (0/10)
- Stability: Mixed (4/10)
- Valuation: Data not available (0/10)
- Ownership: Good (10/15)
Key Facts
Price: $0.05
Market Cap: $1M
Sector: Healthcare
Industry: Medical - Instruments & Supplies
